Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M. A Dubrovina"'
Autor:
D. V. Kurkin, E. E. Abrosimova, D. A. Bakulin, N. S. Kovalev, M. A. Dubrovina, A. V. Borisov, A. V. Strygin, E. I. Morkovin, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 2, Pp 130-153 (2022)
Nitric oxide as a therapeutic approach to the treatment of cardiovascular diseases attracted the attention of researchers at the end of the 19th century. As a vasodilator, nitric oxide may be a unique therapeutic agent for the treatment of hypertensi
Externí odkaz:
https://doaj.org/article/4e3fff5c12294271b8cf6f647278d606
Autor:
D. V. Kurkin, E. I. Morkovin, N. A. Osadchenko, D. A. Bakulin, E. E. Abrosimova, M. A. Dubrovina, N. S. Kovalev, Yu. V. Gorbunova, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 6, Pp 426-435 (2021)
The aim of the study is an experimental confirmation of the use of a new combination of biologically active substances with tonic and antioxidant effects. This combination contains acetylcysteine in its composition to reduce the severity of psychoneu
Externí odkaz:
https://doaj.org/article/1a5992607c6545fe8625adaf05b9f403
Autor:
M E Dubrovina
Publikováno v:
RUDN Journal of Language Studies, Semiotics and Semantics, Vol 8, Iss 3, Pp 563-570 (2017)
The article discusses a fragment of the syntactic subsystem of the Turkic languages, com-plex sentences, from the standpoint of systemic linguistics. Turkic languages have their own features, which often distinguish these languages from the Indo-Euro
Externí odkaz:
https://doaj.org/article/e6b80a92613d4fab91d79a1c4aff22f0
Autor:
I. A. Demina, T. Yu. Verzhbitskaya, S. A. Kashpor, S. A. Plyasunova, M. E. Dubrovina, L. G. Fechina, N. V. Myakova, E. V. Samochatova, A. A. Maschan, A. M. Popov
Publikováno v:
Онкогематология, Vol 12, Iss 1, Pp 55-61 (2017)
Bone marrow tumor blasts immunophenotyping is an essential part of Burkitt lymphoma/leukemia (BL) and B-cell precursor acute lymphoblastic leukemia (BCP-ALL) differential diagnostics. Nevertheless immunoglobulin heavy and light chains detection on th
Externí odkaz:
https://doaj.org/article/b2d72b8b43424c72afdccbce18b588f7
Autor:
I. I. Kalinina, D. A. Venyov, Yu. V. Olshanskaya, M. N. Sadovskaya, O. V. Goronkova, T. Yu. Salimova, U. N. Petrova, D. D. Baidildina, E. V. Suntsova, D. A. Evseev, V. E. Matveev, K. S. Antonova, I. G. Khamin, M. Е. Dubrovina, E. A. Zerkalenkova, M. V. Gaskova, A. M. Popov, S. A. Kashpor, A. I. Mandzhieva, T. V. Konyukhova, L. A. Khachatryan, D. V. Litvinov, D. N. Balashov, L. N. Shelikhova, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:20-35
Over the past years, the outcomes of patients with acute myeloid leukemia (AML) have significantly improved due to the use of intensive chemotherapy, more effective supportive therapy, and the availability of allogeneic hematopoietic stem cell transp
Autor:
E. A. Zerkalenkova, O. I. Illarionova, A. N. Kazakova, N. I. Ponomareva, L. V. Baydun, E. Yu. Osipova, M. E. Dubrovina, A. M. Popov, T. V. Konyukhova, S. A. Plyasunova, N. V. Myakova, A. A. Maschan, Yu. V. Olshanskaya
Publikováno v:
Онкогематология, Vol 11, Iss 2, Pp 21-29 (2016)
Lineage switch is a rare phenomenon in which a transition from lymphoid to myeloid was observed in relapse of acute leukemia, or vice versa. This paper presents the four clinical case reports of acute lymphoblastic leukemia with MLL gene rearrangemen
Externí odkaz:
https://doaj.org/article/1cb2879f77984511ab1e04d6a383de28
Autor:
N. V. Smirnova, N. V. Myakova, M. B. Belogurova, O. V. Ryskal, O. E. Nikonova, G. R. Sharapova, A. S. Fedorova, N. A. Grigorieva, A. V. Shamardina, N. I. Ponomareva, D. S. Abramov, D. M. Konovalov, M. E. Dubrovina, A. A. Maschan, E. V. Samochatova
Publikováno v:
Онкогематология, Vol 10, Iss 4, Pp 15-24 (2015)
The results of two consecutive multicenter clinical trials enrolled 241 patient with childhood mature B-cells non-Hodgkin lymphomas/leukemia are presented. Patients received treatment according B-NHL 2004mab protocol (n = 83) and B-NHL 2010M (n = 158
Externí odkaz:
https://doaj.org/article/469abc7ec64f446c93dbb0d22210eeb6
Autor:
E. A. Matveeva, A. N. Kazakova, I. I. Kalinina, M. E. Dubrovina, L. V. Baydun, M. A. Maschan, Yu. V. Olshanskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 7, Iss 2, Pp 51-56 (2014)
Acute megakaryocytic leukemia (AML M7) – a rare disease characterized by poor treatment response, except for t(1;22) variant in infants. Cytogenetic abnormalities in AML M7 are highly heterogeneous. We collected samples from children with AML M7 to
Externí odkaz:
https://doaj.org/article/3500caa759c74cc487b3235952011626
Autor:
A. A. Maschan, O. O. Molostova, Alexander Popov, D. E. Pershin, M. A. Klimentova, Mikhail Maschan, M. E. Dubrovina, L. N. Shelikhova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:143-147
Presently, there is no consensus on the best treatment for relapsed B-cell acute lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation (allo-HSCT), particularly in patients with extramedullary lesions. There are cer
Autor:
G.A. Novichkova, Y Olshanskaya, Michael Maschan, Alexander Popov, A. A. Semchenkova, S. A. Kashpor, Svetlana Plyasunova, M. E. Dubrovina, E. V. Mikhailova, Elena Zerkalenkova, Alexey Maschan, Irina Kalinina
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:46-53
The aim of this study was to describe the immunophenotype of leukemic cells in acute myeloid leukemia (AML) with inv(16) (p13.1q22)/CBFb-MYH11 and t(16;16)(p13.1;q22)/CBFb-MYH11 in children. This study is supported by the Independent Ethics Committee